Weaver Consulting Group Abbott Laboratories Transaction History

Weaver Consulting Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $116,340 - $126,777	-1,108 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$91.64 - $111.29 $22,910 - $27,822	250 Added 29.14%	1,108 $121,000
Q2 2020 Jul 24, 2020	BUY	$76.57 - $98.0 $26,799 - $34,300	350 Added 68.9%	858 $79,000
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $8,479 - $9,439	108 Added 27.0%	508 $43,000
Q1 2019 Jun 19, 2019	BUY	$66.22 - $80.06 $26,488 - $32,024	400 New	400 $33,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.